Clinical Trials Browser

Phase 2 × Unknown × Oligodendroglioma × Clear all

NCT00276783 2020-03-05

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Phase 2 Unknown

CNSLymphoidSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Lymphoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT02209428 2019-02-21

A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas

Phase 2 Unknown

Astrocytoma, Oligodendroglioma

NCT01403311 2014-03-26

ALA

Phase 2 Unknown

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Gliosarcoma

NCT00004204 2014-01-06

Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

Phase 2 Unknown

Astrocytoma, Brain Neoplasms, Oligodendroglioma, Central Nervous System Neoplasms

NCT00281905 2013-09-20

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Phase 2 Unknown

Astrocytoma, Neuroblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Phase 2 Unknown

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms